Prevalence, Causal Classification, and Prognosis of Patent Foramen Ovale in Young Patients With Embolic Strokes of Undetermined Source
Status In-Process Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
40314393
PubMed Central
PMC12184216
DOI
10.1161/jaha.124.038948
Knihovny.cz E-zdroje
- Klíčová slova
- embolic stroke of undetermined source, patent foramen ovale, stroke,
- Publikační typ
- časopisecké články MeSH
Centre for Neuromuscular and Neurological Disorders University of Western Australia Perth Australia
Clínica Alemana de Santiago Universidad del Desarrollo Santiago Chile
Clinical Neurological Sciences Western University London ON Canada
Department of Brain Sciences Imperial College London London UK
Department of Medicine Temerty Faculty of Medicine University of Toronto Toronto ON Canada
Department of Neurosciences University of Calgary Calgary AB Canada
Kotelawala Defence University Ratmalana Sri Lanka
National Institute of Neurology and Neurosurgery Manuel Velasco Suarez Mexico City Mexico
Neurology Inselspital University Hospital Bern University of Bern Bern Switzerland
Neurology McMaster University Hamilton ON Canada
Perron Institute for Neurological and Translational Science Perth Australia
Policlinico Umberto 1 Hospital Rome Italy
Population Health Research Institute Hamilton ON Canada
St Anne's University Hospital Brno and Tomas Bata Regional Hospital in Zlin Brno Czech Republic
Stanford University School of Medicine Stanford California USA
Statistics Population Health Research Institute Hamilton ON Canada
Vancouver Stroke Program Division of Neurology University of British Columbia Vancouver ON Canada
Zobrazit více v PubMed
Alsheikh‐Ali AA, Thaler DE, Kent DM. Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke. 2009;40:2349–2355. doi: 10.1161/STROKEAHA.109.547828 PubMed DOI PMC
Kent DM, Saver JL, Kasner SE, Nelson J, Carroll JD, Chatellier G, Derumeaux G, Furlan AJ, Herrmann HC, Jüni P, et al. Heterogeneity of treatment effects in an analysis of pooled individual patient data from randomized trials of device closure of patent foramen Ovale after stroke. Jama. 2021;326:2277–2286. doi: 10.1001/jama.2021.20956 PubMed DOI PMC
Perera KS, de Sa Boasquevisque D, Rao‐Melacini P, Taylor A, Cheng A, Hankey GJ, Lee S, Fabregas JM, Ameriso SF, Field TS, et al. Evaluating rates of recurrent ischemic stroke among young adults with embolic stroke of undetermined source: the young ESUS longitudinal cohort study. JAMA Neurol. 2022;79:450–458. doi: 10.1001/jamaneurol.2022.0048. 35285869 PubMed DOI PMC
Koutroulou I, Tsivgoulis G, Tsalikakis D, Karacostas D, Grigoriadis N, Karapanayiotides T. Epidemiology of patent foramen ovale in general population and in stroke patients: a narrative review. Front Neurol. 2020;11:281. doi: 10.3389/fneur.2020.00281 PubMed DOI PMC
Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J; Patent Foramen Ovale and Atrial Septal Aneurysm Study Group . Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740–1746. doi: 10.1056/NEJMoa011503 PubMed DOI